Search - tctmd.com

Displaying 221 - 240 of 496

Sort: Relevancy | Date

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

May 19, 2015

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Daily News

Los BRF son Equiparables a los SLF en el Tratamiento de Pacientes ‘del Mundo Real’ con Reestenosis Intra-Stent

March 04, 2015

News Daily News

DCB与DES的“真实”支架内再狭窄患者治疗效果相当

March 04, 2015

News Daily News

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

March 04, 2015

News Daily News

第 3 年 XAMI 率：急性心梗患者置入 EES 和 SES 的极晚期支架血栓事件率同样较低

L.A. McKeown

January 29, 2015

News Daily News

XAMI at 3 Years: Rates of Very Late Stent Thrombosis Similarly Low for EES, SES in Acute MI Patients

L.A. McKeown

January 29, 2015

News Daily News

XAMI a los 3 Años: Similares Índices Bajos de Trombosis Muy Tardía del Stent para SLE, SLS y Pacientes que sufren IAM

L.A. McKeown

January 29, 2015

News Daily News

含可生物降解聚合物的 DES 可安全使用、耐用长达 5 年

L.A. McKeown

January 28, 2015

News Daily News

Los SLF con Polímero Biodegradable son Seguros y Duraderos al cabo de 5 Años

L.A. McKeown

January 28, 2015

News Daily News

DES With Biodegradable Polymer Safe, Durable Through 5 Years

L.A. McKeown

January 28, 2015

News Daily News

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

December 14, 2014

News Daily News

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

Salynn Boyles

December 11, 2014

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Daily News

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

Yael L. Maxwell

November 17, 2014

News Daily News

SECURITY: 6 Meses de Terapia Antiplaquetaria Doble No son Inferiores a 12 Meses en Pacientes de Bajo Riesgo Post-PCI

Yael L. Maxwell

November 17, 2014

News Daily News

SECURITY：在PCI后的低风险患者中，6个月DAPT相对于12个月的该策略具有非劣效性

Yael L. Maxwell

November 17, 2014

News Conference News AHA 2014

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

Yael L. Maxwell

November 15, 2014

Advertisement

Trials Explore the Potential of Biodegradable-Polymer Stents

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Los BRF son Equiparables a los SLF en el Tratamiento de Pacientes ‘del Mundo Real’ con Reestenosis Intra-Stent

DCB与DES的“真实”支架内再狭窄患者治疗效果相当

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

第 3 年 XAMI 率：急性心梗患者置入 EES 和 SES 的极晚期支架血栓事件率同样较低

XAMI at 3 Years: Rates of Very Late Stent Thrombosis Similarly Low for EES, SES in Acute MI Patients

XAMI a los 3 Años: Similares Índices Bajos de Trombosis Muy Tardía del Stent para SLE, SLS y Pacientes que sufren IAM

含可生物降解聚合物的 DES 可安全使用、耐用长达 5 年

Los SLF con Polímero Biodegradable son Seguros y Duraderos al cabo de 5 Años

DES With Biodegradable Polymer Safe, Durable Through 5 Years

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

SECURITY: 6 Meses de Terapia Antiplaquetaria Doble No son Inferiores a 12 Meses en Pacientes de Bajo Riesgo Post-PCI

SECURITY：在PCI后的低风险患者中，6个月DAPT相对于12个月的该策略具有非劣效性

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content